A randomised, double blind trial was carried out in 16 patients undergoing pleurectomy to assess the effect of continuous extrapleural intercostal block on postoperative pain and pulmonary function. Subjective pain relief was assessed on a linear visual analogue scale. Pulmonary function was measured on the day before operation and daily for five days after surgery. Eight patients received bupivacaine and eight placebo (saline). The mean pain scores at 4, 8, 16, and 24 hours were 13-3, 8 5, 61, and 10 mm respectively in the bupivacaine group compared with 56 3, 41, 46-7, and 35 in the control group; in addition, the bupivacaine group required less papaveretum. Twenty four hours after surgery mean values of peak expiratory flow, forced expiratory volume in one second, and forced vital capacity were reduced to 82%, 76%, and 76% of preoperative control values in the bupivacaine group, and to 39%, 32%, and 36% in the control group. The speed of recovery of pulmonary function was superior in the bupivacaine group. There were no complications related to the infusion. Continuous extrapleural intercostal nerve blockade with bupivacaine provides safe and effective postoperative analgesia and improves respiratory mechanics after pleurectomy.
Spontaneous pneumothorax may be primary (idiopathic) or secondary to underlying pulmonary disease. Spontaneous pneumothorax usually occurs in the third and fourth decades of life from rupture of a subpleural bleb,' and it resolves with observation or tube drainage in 80-90% of cases.2 A parietal pleurectomy is indicated for recurrent pneumothoraces (three ipsilateral pneumothoraces) and a first contralateral pneumothorax, and for failure to respond adequately to management by tube drainage,'3 if the patient is fit enough for a thoracotomy.
Thoracotomy causes severe postoperative pain and considerable impairment of pulmonary function. 4 These changes are worst in the elderly, the obese, smokers, and those with pre-existing cardiopulmonary disease. 5 (5 ml/h for patients weighing 50-59 kg, 6 ml/ h for 60-69 kg, 7 ml/h for 70-79 kg, 8 ml/h for 80-89 kg, 9 ml/h for 90-99 kg, and Mean (SD) body weight (kg) 79 (9) 69 (9) Mean ( 484 (53) 485 (43) 10 ml/h for 100 kg and over). The infusate was prepared for each patient by the pharmacy department. The infusions were continued until the morning of the fifth postoperative day. This did not restrict patients' mobility as the infusion pump was portable and could be disconnected for short periods.
The randomisation code was available to the investigators at all times in case of emergency. Staff taking measurements and setting up the infusions were not told which infusate was being given. In our study continuous intercostal nerve block with bupivacaine resulted in a smaller decline in FEV,, FVC, and PEF at 24 hours than occurred in the control group and much more rapid recovery. Better postoperative analgesia resulted in considerably less need for narcotics. The patients were able to comply with vigorous physiotherapy easily because pain was minimal, and they required little sedation. The mechanism of action of continuous intercostal nerve block administered extrapleurally depends primarily on its paravertebral spread.8 This allows the local anaesthetic agent to bathe not only the ventral nerve roots but also the posterior primary rami and afferent fibres of the sympathetic chain. The posterior primary rami supply the posterior ligaments, posterior spinal muscles, and overlying skin, which are traumatised at posterolateral thoracotomy.20 The pain from a thoracotomy also comes from visceral pleura and organs innervated by afferent fibres in sympathetic nerves.
We recently reported that continuous extrapleural intercostal nerve block provided safe, effective analgesia and substantial improvement in respiratory mechanics in 56 patients undergoing elective thoracotomy.8 These patients, however, had intact pleura. The present study was designed to determine whether the same results were possible in patients after pleurectomy. The technique of parietal pleurectomy was slightly modified to preserve the integrity of the parietal pleura, which covers the paravertebral space. Some of our analgesia would undoubtedly be due to intrapleural seepage of bupivacaine. Direct intrapleural bupivacaine has given variable degrees of postoperative pain relief after thoracotomy, however, in other studies. [21] [22] [23] We have not encountered complications related to the technique or from continuous infusion of bupivacaine at the dosage described in this report. We conclude that continuous extrapleural intercostal nerve block is a safe and reliable method of providing analgesia after parietal pleurectomy, which helps to preserve lung function and is without important side effects.
